Awareness of the pharmaceutical industry has increased significantly in the last 12 months due to the global pandemic. The timely production and delivery of vaccines at capacity has been a major issue across the world, and the way the industry has responded to meet that challenge has undoubtedly driven knowledge and lessons learnt which should be captured to continually improve the industry. Additionally, it can be argued that the pharmaceutical industry is changing at its fastest rate in decades, driven in part by the requirement to manufacture new process modalities, as well as the need to deliver new facilities in a quicker and more cost effective manner. Furthermore, growing demand for more flexible and sustainable facilities, together with the advancement of new processing and Pharma 4.0 technologies, such as digitization and robotics, requires that Site Master Planning needs to advance accordingly. This session will hear about the new Vaccines Manufacturing and Innovation facility in the UK and how it responded to the pandemic challenge, and also, how its design basis changed to become platform and technology agnostic with the ability to ramp capacity 20 fold with a 6 month timeframe. Additionally, the session will look at Site Master Planning the Future and how it should adjust to accommodate new process modalities, delivery methods, and Pharma 4.0 technologies.
[Masterplanning the Future]
Speakers: Jordaan Kemp and Jessica Hays
Will be a comprehensive outlook on some of the most relevant Pharmaceutical developments in the world that are configuring a new understanding on the role of master plans. In a time of faster project delivery, evolution of process modalities, products and production processes, growing demands for more flexible processes and facilities and a shift in company objectives, the traditional modernist planning model might be transitioning to a new stage and this is the hypothesis and starting point of the presentation. We will look at the following key areas that affects how we plan and arrange our site masterplans for clients: modular design solutions; flexibility; adaptable modules; the drivers for pre-investments to assist speed to market; impact of the various modalities on support functions and designing for adaptability; impact of robotics and the integration of cobots • digitization and next generation technological developments; designing a sustainable future ; well building design and creating great working environment. Our new generation of masterplanning methodology is testing renewed strategies to understand and plan sites, and by also using the intersection of the digital and physical, to display information and communicate within client organizations to help plan their futures.
[Building a Facility for International Collaboration: The UK’s Vaccines Manufacturing and Innovation Centre]
Speaker: Matthew Duchars